DHEA for women is a hormone supplement that may help restore declining levels of a key precursor involved in estrogen and testosterone production — with the most studied applications in postmenopausal women dealing with vaginal atrophy, low libido, and hormonal fatigue, subject to medical approval by a licensed provider.
DHEA — dehydroepiandrosterone — is a hormone produced mainly by your adrenal glands. At its peak around age 25, DHEA production begins a steady decline of about 2% per year. By menopause, most women have roughly 10–20% of the DHEA they had at their youthful peak.
That matters because DHEA is the upstream precursor for nearly all circulating estrogens and androgens in postmenopausal women. Once the ovaries stop producing estrogen directly, peripheral conversion of DHEA in tissues becomes the primary source of sex hormones.
At TelosRX, DHEA as a hormone support option is evaluated asynchronously by licensed providers — no in-person visit required.
What Is DHEA and How Does It Work in Women?
DHEA is classified as a prohormone — it's biologically inactive until converted downstream. In the body, DHEA is sulfated in the liver to DHEA-S (the storage form), then converted in peripheral tissues to active androgens (testosterone) and estrogens (estradiol) as needed.
This is important for women specifically:
- In postmenopausal women, peripheral DHEA conversion accounts for 100% of estrogen production (the ovaries have stopped contributing)
- DHEA-to-testosterone conversion supports libido, energy, and muscle maintenance
- DHEA-to-estradiol conversion at tissue sites supports bone density, vaginal tissue, and cognitive function
Because conversion happens in peripheral tissues (skin, bone, adipose tissue, and vaginal tissue), the hormonal effects are partly self-regulating — a different pharmacological profile than taking estrogen or testosterone directly.
DHEA Levels by Age in Women
| Age Range | Approximate DHEA-S Range (Women) | Typical Trend |
|---|---|---|
| 20–29 | 150–380 μg/dL | Peak production |
| 30–39 | 100–300 μg/dL | Gradual decline begins |
| 40–49 | 60–220 μg/dL | Noticeable decline |
| 50–59 | 30–145 μg/dL | Post-menopause drop |
| 60+ | 20–100 μg/dL | Continued low |
These are reference ranges, not targets. What matters clinically is your individual baseline and symptoms, not simply matching a number. Baseline testing is part of the asynchronous evaluation at TelosRX.
DHEA Benefits for Postmenopausal Women: What Research Shows
A 2022 meta-analysis published in Frontiers in Endocrinology reviewed 21 randomized controlled trials (RCTs) evaluating DHEA supplementation in postmenopausal women. Key findings:
- DHEA at doses of ≥50 mg/day significantly increased testosterone levels in postmenopausal women across trials
- In women aged 60+, the same dose range also significantly elevated estradiol levels
- Effects were dose-dependent: higher doses (50–75 mg/day) produced larger hormonal shifts than lower doses (25 mg/day)
A complementary review, "Should Dehydroepiandrosterone Be Administered to Women?" in Endocrine Reviews, assessed DHEA's specific applications:
- Vaginal atrophy (GSM): Intravaginal DHEA (prasterone) has the strongest evidence base — FDA-approved in prescription form (Intrarosa) for dyspareunia from vaginal atrophy
- Sexual function: Mixed results in oral supplementation trials; modest improvements in desire and lubrication in some studies
- Bone density: Some evidence of protective effects on bone mineral density, consistent with the role of estrogen and testosterone in bone remodeling
- Mood and energy: Observational improvements reported, but RCT data is inconsistent
DHEA for Women: Sexual Health and Libido
Low libido in women after menopause is partly hormonal — reduced testosterone and estrogen both contribute. DHEA supplementation's effects on sexual function are real but modest in most trial data:
- A trial published in the Journal of Sexual Medicine found that 50 mg/day oral DHEA led to improvements in sexual desire, arousal, and frequency of activity in postmenopausal women over 6 months, compared to placebo
- Intravaginal DHEA (Intrarosa, prasterone) has stronger evidence specifically for dyspareunia (pain during sex) from vaginal atrophy — this is an FDA-approved prescription indication
- The mechanism: local DHEA conversion to estradiol and testosterone in vaginal tissue restores tissue health without systemic hormone spikes
For context on how hormone support integrates with other longevity protocols, see the TRT evaluation guide or the pregnenolone research overview — both involve related hormonal pathways.
DHEA Dosage for Women: What Studies Used
| Application | Dose Range Studied | Route | Evidence Quality |
|---|---|---|---|
| General postmenopausal hormonal support | 25–75 mg/day | Oral | Multiple RCTs |
| Vaginal atrophy / dyspareunia | 6.5 mg/day (prasterone) | Intravaginal | FDA-approved indication |
| Sexual function | 50 mg/day | Oral | Moderate RCT evidence |
| Bone density support | 50–100 mg/day | Oral | Limited RCT evidence |
No universal "right dose" exists. The 2022 meta-analysis found that doses below 50 mg/day had inconsistent effects on testosterone and estradiol levels in postmenopausal women. Any supplementation protocol is subject to medical approval by a licensed provider and should be based on your baseline hormone levels and symptoms.
DHEA Side Effects in Women
DHEA is generally well-tolerated at doses up to 50 mg/day for periods up to 2 years, based on available trial data. Side effects are dose-related and androgenic (from testosterone conversion):
- Acne: Most common androgenic side effect, particularly at higher doses (>50 mg/day)
- Oily skin: Related to testosterone-stimulated sebum production
- Facial hair: Rare at standard doses; more common at 75–100 mg/day
- Mood changes: Irritability or mood shifts reported in some studies, not consistent across trials
- Hair thinning: Theoretically possible with high androgens; not consistently demonstrated in trial data
At doses ≤25 mg/day, androgenic side effects are uncommon. DHEA is a hormone — it has real physiological effects and should not be treated as a benign supplement.
Who Should Not Use DHEA
DHEA is not appropriate for everyone. Your provider will evaluate:
- History of hormone-sensitive cancers (breast, ovarian, endometrial) — DHEA converts to estrogen and testosterone, which can be contraindicated
- Polycystic ovary syndrome (PCOS) — elevated androgens are already present
- Liver disease — DHEA is metabolized hepatically
- Current use of insulin, thyroid medications, or anticoagulants — interactions are possible
Subject to medical approval by a licensed provider. TelosRX's asynchronous evaluation includes a full health history review before any protocol is approved.
How DHEA Fits Into a Broader Longevity Protocol
DHEA doesn't work in isolation. It's one lever in a broader hormonal and metabolic system. Women exploring DHEA for longevity and hormonal support often also evaluate:
- Sermorelin — a growth hormone-releasing peptide that addresses the GH axis, which also declines with age
- NAD+ — mitochondrial energy support that complements hormonal optimization
- Sleep optimization — DHEA production follows circadian rhythms and is blunted by poor sleep
DHEA and Cognitive Function in Older Women
Some researchers have investigated whether DHEA supplementation supports cognitive function in postmenopausal women, given that estrogen and testosterone are neuroprotective hormones that decline with age.
The evidence is mixed. A clinical trial published in Brain Research found that DHEA administration increased androgen and estrogen levels in postmenopausal women but did not significantly improve short-term memory performance compared to placebo. Other studies report improvements in subjective mood, energy, and sense of well-being at doses of 50 mg/day over 12 months.
DHEA's effects on cognition and mood in women are not consistently demonstrated in controlled trials. Where effects appear, they tend to be modest and may relate more to overall hormonal support than direct neurological action. Larger, longer-duration trials are needed.
DHEA and Adrenal Health in Women
DHEA production is primarily adrenal. In cases of adrenal insufficiency — where the adrenal glands are impaired by disease, chronic stress, or medical treatment — DHEA levels fall sharply. For women with documented adrenal insufficiency, DHEA replacement is a recognized treatment option supported by endocrinology guidelines in some countries.
However, "adrenal fatigue" — a loosely defined and contested concept — is frequently cited as justification for DHEA supplementation in wellness contexts. The scientific literature doesn't support this indication. DHEA testing in otherwise healthy, non-adrenal-insufficient individuals often returns normal values, and supplementation in the absence of documented deficiency carries a different risk-benefit calculation. Subject to medical approval by a licensed provider, with baseline testing as part of any protocol at TelosRX.
Frequently Asked Questions
What does DHEA do for a woman?
DHEA is a hormone precursor that converts to estrogen and testosterone in peripheral tissues. In postmenopausal women, it's the primary source of those hormones. Clinically studied applications include supporting vaginal tissue health, sexual function, bone density, and energy. Effects vary by individual baseline levels and dose. Subject to evaluation by a licensed provider.
How much DHEA should a woman take?
Studies in postmenopausal women have used 25–75 mg/day orally. The 2022 meta-analysis found doses ≥50 mg/day were needed to significantly elevate testosterone levels. No standard dosing recommendation exists without individual hormone testing. Any DHEA protocol requires medical approval by a licensed provider.
What are the side effects of DHEA for women?
Side effects are androgenic — acne, oily skin, and occasionally facial hair or mood changes — and are dose-dependent. They're most common at doses above 50 mg/day. DHEA is generally considered safe for periods up to 2 years at doses ≤50 mg/day based on available RCT data.
Does DHEA help with menopause symptoms?
The most consistent evidence is for vaginal atrophy symptoms: intravaginal DHEA (prasterone/Intrarosa) is FDA-approved for dyspareunia from vaginal atrophy. Oral DHEA shows mixed results for general menopausal symptoms. Some women report improvements in energy, mood, and libido; RCT data on these endpoints is inconsistent. Subject to provider evaluation.
Can DHEA improve libido in women?
Multiple trials have evaluated DHEA's effect on sexual function in postmenopausal women. Results are mixed: some RCTs showed modest improvements in desire, arousal, and frequency of sexual activity at 50 mg/day; others showed minimal change vs. placebo. Intravaginal DHEA has stronger evidence for reducing pain during sex due to vaginal atrophy.
Is DHEA safe for women?
DHEA is generally considered safe at doses up to 50 mg/day for up to 2 years based on available data. It is a hormone, not a vitamin — it has real physiological effects and is contraindicated in certain conditions, including hormone-sensitive cancers. Always subject to evaluation by a licensed provider before starting.
Does DHEA increase estrogen in women?
In postmenopausal women, yes — at doses ≥50 mg/day, meta-analysis data shows significant estradiol elevation, particularly in women over age 60 with longer supplementation periods (≥26 weeks). This is the mechanism behind its use for vaginal atrophy and related symptoms. Lower doses may not reliably elevate estradiol.
What time of day should women take DHEA?
Morning is most often recommended because DHEA naturally peaks in the morning following cortisol release. Taking it with the morning meal may improve tolerability and align better with the body's natural hormonal rhythm. Your provider may give specific guidance based on your protocol.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.